Article summary

Late-May 2026 UK director dealings split between sell-offs at Ashmore, Luceco, Card Factory, Hill & Smith, Reabold and Star Energy, and insider buys at CVS, Naked Wines, Pharos, Auto Trader, BAT, Centrica and others.

Named-director data on both sides — Glover and Ward at Star Energy on the sells; Morrison, Roe and Pailing on the buys — provide concrete reference points.

Comparing both sides supports a more disciplined reading than focusing on either alone.

 

Two sides of the UK insider activity ledger

Comparing director sell-offs with insider buys within the same reporting window is one of the more rigorous ways to interpret UK director dealings. The Sharecast Director Dealings index for 26 and 27 May 2026 provides a clear two-sided dataset to work with: a substantial Buy-Side list across FTSE 100, FTSE 250 and AIM names, and a more concentrated Sell-Side list anchored by activity at Ashmore Group, Luceco, Card Factory, Hill & Smith, Reabold Resources and Star Energy Group.

On the buys side, three named transactions provide analytical anchors: Scott Morrison at CVS Group (£12,531.75 at 1,269.68p), Katherine Roe at Pharos Energy (£1,472.63 at 27.50p) and Jack Pailing at Naked Wines (£39,562.50 at 75.00p across two trades). On the sells side, the Star Energy disclosures — Ross Glover (£46,326.56) and Frances Ward (£9,676.00), both at 16.00p — provide the clearest named data.

Together, these named transactions account for £53,566.88 of insider buy value and £56,002.56 of insider sell value across the named entries, a remarkably close balance for the data points where line-level detail is available.

What the sells side reveals

The sells side is more concentrated than the buys side, with Luceco alone accumulating four sell entries on 26 May 2026 and a further entry on 27 May. Ashmore Group records two entries spanning both 26 and 27 May, Card Factory two entries on 26 May, and Hill & Smith, Reabold Resources and Star Energy each one or two entries on 26 May.

Star Energy's two named-director sells provide the clearest disclosure, with the matching 16.00p price across both transactions suggesting a single market level was applied to dealings on the day. Combined proceeds of approximately £56,002 sit at the small-cap end of the disclosure spectrum.

Most other sell entries lack line-level detail in the version of the source reviewed. The corresponding RNS notifications would set out the directors, share counts and prices for each transaction.

What the buys side reveals

The buys side is broader, spanning FTSE 100 (BAT, Centrica, Auto Trader), FTSE 250 (Caledonia Investments, CVS Group, Greencore, Jupiter Fund Management, Convatec, Genuit Group), AIM (Naked Wines, Pharos Energy, Tapir Holdings, NB Equity/">Private Equity Partners) and trust (Baillie Gifford Shin Nippon) names. The diversity of sectors covered is one of the more striking features of the data.

Three named-director buys provide analytical anchors at CVS Group, Pharos Energy and Naked Wines. The Convatec entry on 26 May is complemented by a separately reported Convatec CEO purchase on 27 May, providing additional evidence of senior insider activity at the medical products specialist.

Insider buys typically carry stronger informational content than sells, so the breadth and specificity of the buy list provides a moderately constructive sentiment input at the UK market level.

Signal asymmetry between buys and sells

A core principle of director dealings analysis is that buys typically carry more information than sells. Buys involve directors deploying personal Capital with a single discretionary aim — gaining exposure to a stock they believe is mispriced. Sells can reflect remuneration timing, tax planning, Diversification and personal financial decisions unrelated to a view on the Business.

Applied to the late-May 2026 UK data, this asymmetry suggests that the buy-side breadth and named-director purchases deserve relatively more weight than the concentrated but largely unspecified sell-side entries. Even Star Energy's named sells should be read in the context of remuneration mechanics and residual holdings, which the RNS would clarify.

Nonetheless, no single signal in isolation is dispositive. The transactions do not necessarily indicate a change in fundamentals on either side, and disciplined integration with other inputs is the right approach.

Sector splits and what they reveal

Consumer-facing names show insider activity on both sides: buys at Naked Wines (turnaround), Greencore (convenience food) and BAT (tobacco/nicotine); sells at Card Factory (value retail). Industrial names also split, with buys at Genuit Group and sells at Hill & Smith. Asset management features on the buys side (Jupiter Fund Management, Caledonia Investments) and the sells side (Ashmore Group).

Energy splits between buys at Pharos Energy and Centrica and sells at Reabold Resources and Star Energy Group. Property features only on the buys side (CLS Holdings), and medical products only on the buys side (Convatec). The composition reflects the diversity of UK markets rather than a single thematic driver.

These sector splits are a reminder that insider sentiment is rarely uniform across a market. Investors should weigh both sides at the company level rather than try to derive a sector signal from the headline data.

Risks and opportunities for investors comparing both sides

Risks include over-weighting either side of the watchlist, missing the company-specific drivers behind each disclosure and treating the data as a directional market signal when the underlying detail is mixed. Insider activity should always be one input among many.

Opportunities lie in identifying names where insider activity aligns with other constructive or cautious inputs. The named-director buys at CVS Group, Pharos Energy and Naked Wines are particularly useful starting points for follow-up analysis, while the named sells at Star Energy can be paired with the company's most recent operational disclosures.

The transactions do not necessarily indicate a change in fundamentals on either side, but they do provide useful prompts for analytical work.

A balanced conclusion on the two-sided UK insider signal

Comparing director sell-offs with insider buys in the late-May 2026 UK reporting window supports a mixed reading rather than a clean directional call. The buy-side breadth and three named-director purchases provide a moderately constructive sentiment input, while the sell-side concentration at certain names — anchored by Star Energy's named disclosures — provides a useful counterweight.

For investors, the right response is to use the two-sided watchlist as a prompt to revisit equity stories and prioritise analytical work, not to derive a clean directional call from the data alone. The named transactions provide concrete starting points, while the broader entries call for RNS review and integration with other inputs.

Above all, the disciplined approach is to treat both sides of the ledger as useful prompts for further work rather than as stand-alone trading signals.